HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dihydrokavain

inhibits binding of batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated sodium channels

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Pyrones: 35
      - dihydrokavain: 2

Experts

1.	Leitzman, Pablo: 2 articles (01/2017 - 11/2016)
2.	Narayanapillai, Sreekanth C: 2 articles (01/2017 - 11/2016)
3.	Upadhyaya, Pramod: 2 articles (01/2017 - 11/2016)
4.	Xing, Chengguo: 2 articles (01/2017 - 11/2016)
5.	Hecht, Stephen S: 1 article (01/2017)
6.	O'Sullivan, M Gerard: 1 article (01/2017)
7.	Puppala, Manohar: 1 article (01/2017)
8.	Sun, Haifeng: 1 article (01/2017)
9.	Baglole, Carolyn J: 1 article (11/2016)
10.	Lin, Shang-Hsuan: 1 article (11/2016)

Related Diseases

1.	Lung Neoplasms (Lung Cancer) 01/01/2017 - "(+)-Dihydromethysticin was recently identified as a promising lung cancer chemopreventive agent, while (+)-dihydrokavain was completely ineffective. "
2.	Body Weight (Weight, Body) 11/21/2016 - "DHM (0.05, 0.2, and 1.0 mg/g of diet) and dihydrokavain (DHK, an inactive analogue, 1.0 mg/g of diet) were given to mice for 7 days, followed by a single intraperitoneal dose of NNK at 100 mg/kg of body weight. "

Related Drugs and Biologics

1.	7,8-dihydromethysticin